The leader in quality education and networking through//conferences, courses and custom training
Connect with IBC Life Sciences:LinkedIn iconTwitter iconFacebook iconRSS icon
EmailPrint

TIDES: Oligonucleotide and Peptide® Therapeutics from Research through Commercialization

CSS

Agenda CSS

Access the hottest fields in therapeutics by attending TIDES - the only event with full coverage of discovery, development and manufacturing

May 12-15, 2013
Hynes Convention Center
Boston, MA

Alt Language

Alternate Language Options:

  • Japanese
  • Korean
  • Taiwanese
  • Chinese

Agenda Summary

Agenda Summary

Comprehensive Updates Spanning the Entire Development Process

  • To view agenda details: Click the underlined links within the glance below (where applicable) to view the detailed agenda for that track, course, keynote or plenary session.
  • To view the complete agenda: Please download the PDF brochure.
Course #1:
Application of Current FDA and ICH Guidelines to the Manufacturing and Analysis of Oligonucleotides
Course #2:
Business and Operational Strategies for Successful Peptide Development
Course #3:
Peptide and Oligonucleotide Conjugation Strategies
Course #4:
Physicochemical Characterization of Oligonucleotides and Peptides
Keynote Presentations
Plenary Session: Updates on Commercialization of Therapeutic Candidates
Oligonucleotide and Peptide Manufacturing, Technology and Product Development Oligonucleotide Therapeutics Discovery Peptide Discovery and Development Nucleic Acids Technologies for Molecular Diagnostics
Oligonucleotide and Peptide Manufacturing, Technology and Product Development Oligonucleotide Therapeutics Discovery Peptide Discovery and Development Nucleic Acids Technologies for Molecular Diagnostics
Bioprocess Training Academy